Internal Medicine, Pulmonary Disease · Altoona, PA
NPI
1114121647
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
800 Chestnut Ave
Altoona, PA, 16601
Phone (814) 946-2846
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
3,006 services
Medicare patients, 2024
522
Average age 76
Drug cost, 2024
$2.1M
3,251 prescriptions
Company payments, 2025
$114K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Zlupko was code 99232 (hospital e&m - subsequent), 1,070 times for 234 patients. In total Michael Zlupko billed 3,006 services in 35 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,070 | 234 | $59.35 | $64K |
| 99214 Office E&M - Established | Office | 434 | 235 | $86.63 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 351 | 160 | $89.43 | $31K |
| 94010 Pulmonary Function Testing | Office | 282 | 167 | $19.22 | $5,420 |
| 94729 Pulmonary Function Testing | Office | 146 | 102 | $39.94 | $5,831 |
| 99223 Hospital E&M - Initial | Facility | 78 | 69 | $130.08 | $10K |
| 94060 Pulmonary Function Testing | Office | 68 | 60 | $24.97 | $1,698 |
| 94727 Pulmonary Function Testing | Office | 66 | 61 | $30.54 | $2,016 |
| 99222 Hospital E&M - Initial | Facility | 65 | 63 | $97.79 | $6,357 |
| 99205 Office E&M - New | Office | 39 | 39 | $148.30 | $5,784 |
| 99213 Office E&M - Established | Office | 24 | 21 | $50.51 | $1,212 |
| G0008 Administration of influenza virus vaccine | Office | 23 | 23 | $23.43 | $539 |
| 99231 Hospital E&M - Subsequent | Facility | 21 | 13 | $37.37 | $785 |
| 90653 Vaccine Product | Office | 21 | 21 | $63.70 | $1,338 |
| 71046 X-ray - Chest | Office | 21 | 20 | $22.41 | $471 |
By year: 2022 $102K for 2,345 services; 2023 $168K for 3,259 services; 2024 $181K for 3,006 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Zlupko prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 796 prescriptions and refills. In total Michael Zlupko wrote 3,251 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 796 | 960 | 140 | $593K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 393 | 437 | 110 | $13K |
| Montelukast Sodium Generic | 252 | 432 | 44 | $3,343 |
| Breo Ellipta Fluticasone/Vilanterol | 223 | 320 | 41 | $122K |
| Prednisone Generic | 195 | 317 | 101 | $795 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 155 | 207 | 30 | $31K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 110 | 124 | 18 | $55K |
| Azithromycin Generic | 108 | 194 | 61 | $1,360 |
| Roflumilast Generic | 95 | 142 | 20 | $8,025 |
| Spiriva Respimat Tiotropium Bromide | 93 | 135 | 19 | $66K |
| Ventolin Hfa Albuterol Sulfate | 68 | 80 | 20 | $4,149 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 64 | 84 | 16 | $15K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 55 | 81 | 14 | $36K |
| Advair Hfa Fluticasone Propion/Salmeterol | 35 | 38 | Under 11 | $13K |
| Nucala Mepolizumab | 35 | 42 | Under 11 | $155K |
Brand drugs: 1,986 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Zlupko $114K ($114K in general payments such as food, travel and fees) from 26 companies. The largest payer was GlaxoSmithKline, LLC. with $49K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 78 | $49K |
| Regeneron Healthcare Solutions, Inc. REGN | 28 | $35K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 31 | $22K |
| Grifols USA, LLC | 11 | $5,800 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $517 |
| Genzyme Corporation SNY | 6 | $402 |
| Resmed Corp RMD | 1 | $156 |
| Insmed, Inc. INSM | 13 | $149 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $146 |
| Axsome Therapeutics, Inc. AXSM | 2 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.